Myriad Genetics is proud to announce that our Prequel® Prenatal Screen is now available at eight weeks gestational age. Get more insights more efficiently by ordering at your patients' first OB appointment. Learn more at https://lnkd.in/giCiw_qe. Read more from our press release: https://lnkd.in/g8zW88M3 #innovation #pregnancy #genetictesting
Myriad Genetics
Biotechnology Research
Salt Lake City, Utah 87,814 followers
We're a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all.
About us
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
- Website
-
http://www.myriad.com/
External link for Myriad Genetics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Salt Lake City, Utah
- Type
- Public Company
- Founded
- 1991
- Specialties
- Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
Locations
Employees at Myriad Genetics
Updates
-
GeneSight.com has a fresh look! With improved navigation, more interactive features, and an improved, cohesive design, our new site is crafted to enhance the experience for both patients and providers. Take a look at what’s new: https://lnkd.in/eQfJ92w #GeneSight #MentalHealth #WebsiteUpdate
-
-
Tim pursued germline testing to find out if there was a DNA mutation running through his family that could impact his children in the future. Learn how certain #genetictests like Myriad's MyRisk Hereditary Cancer Testing can provide information for prostate cancer treatment decisions, and help inform patients' family of their potential cancer risks. https://brnw.ch/21wOL6l #FamilyHealthHistoryMonth #geneticinsights #BRCA #hereditarycancer
-
-
We're live at #CGAIGC24! Stop by booth # 25 to meet our team. Connect with us to learn how Myriad can support your practice with genetic and genomic testing options for every step in your patients' journey. #geneticcounseling #teamMyriad #partnerincare #CGAIGC
-
-
We’re thrilled to share that 3 million patients (and counting!) have now taken the GeneSight test! 🧬 We're so grateful to the dedicated healthcare providers who order the test for their patients, our incredible team working behind the scenes, and, of course, to every one of the 3 million individuals on their unique mental health journey. Curious how providers are using the #GeneSight test? Read their stories here: https://lnkd.in/gPq-kFK6 #mentalhealth #patientcare #innovation #healthcareprofessionals
-
🏆 Thrilled to share that our Women's Health team, led by Melissa Gonzales, Marie Mount and Georgia Heller, has been awarded a silver AdAge Healthcare Marketing Impact Award in the "Small but Mighty" category for our 2023 "Get Ahead of Breast Cancer" campaign! 🎉 This recognition reflects our commitment to empowering people with important knowledge and informed medical management decision-making in the fight against #breastcancer. A huge congratulations to everyone involved in developing this campaign, including our agency partner S50! Here's to many more impactful initiatives in 2025 and beyond. 💙 Learn more: https://lnkd.in/gT82Ea_y #teamMyriad #award #breastcancerawareness #healthcaremarketing
-
-
That's a wrap on #LUGPA24, Day 1! We’d like to thank Kara Cossis PA-C, MPH and Rob Finch for leading an insightful discussion at our Advancing Prostate Cancer Care with Genetic Testing session earlier today. Stop by our booth (# 225) tomorrow to learn more about our comprehensive suite of genetic tests for a full prostate cancer work up. #genetictesting #biomarkers #prostatecancer #urology LUGPA
-
-
Get ready for #CGAIGC! We look forward to seeing you for: 📊 Evidence-Driven Insights: We're showcasing 3 data-backed poster presentations. Discover how integrating these research findings into your practice can elevate the care you provide. 📍 Stop by booth # 25 and join us. We look forward to connecting with you! #geneticcounseling #CGAIGC24 #genetictesting
-
-
🎉 Today is Genetic Counselor Awareness Day and we're thrilled to celebrate the dedication and impact of all of our incredible genetic counselors at Myriad Genetics. With over 100 genetic counselors in diverse roles across our organization, we are uniquely equipped to fulfill our mission of uncovering the answers within everyone through genetic information. Our genetic counselors' expertise and dedication to #patientcare ensures that each person receives the guidance they need on their genetic journey. We're also celebrating a remarkable milestone, as our Patient Education team has now helped over 500,000 patients with essential education both before and after genetic testing! This incredible achievement reflects our deep commitment to patient care, going above and beyond to create connections, build trust, and empower individuals to make informed decisions about their health and medical. Thank you to our genetic counselors for making a difference every day by being at the heart of our mission and guiding patients and healthcare providers with expertise, compassion, and support. 💙 #teamMyriad #genetictesting #geneticcounseling
-
Prolaris® testing helps answer your #prostatecancer patients most pressing questions by combining clinical pathological features like PSA and Gleason, with a personalized molecular score to determine their risk for disease-specific mortality (DSM) and metastasis (mets), making it the most comprehensive biomarker test available. Learn how to incorporate Prolaris testing into your practice https://lnkd.in/g8XfVe9z #genetictesting #biomarkers
-
Affiliated pages
Similar pages
Browse jobs
Stock
MYGN
NASDAQ
20 minutes delay
$14.98
-0.245 (-1.61%)
- Open
- 15.12
- Low
- 14.77
- High
- 15.678
Data from Refinitiv
See more info on